Bristol Myers Squibb BMY
NYSE BMY
$61.69 +2.85 (+4.85%)
As of: Oct 20, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Gross Margin (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Gross Margin of 71.28% for Q2 2026, down 1.24 percentage points from 72.52% a year earlier but up 1.06 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Gross Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Bristol Myers Squibb was 70.16%, down 0.13 percentage points year-over-year; for FY2025, it came in at 71.08%, unchanged from FY2024.

  • Annual Gross Margin shows a five-year change of -1.23 percentage points (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Gross Margin was 71.08% in FY2024 (-5.16 pp), 76.24% in FY2023 (-1.80 pp), 78.04% in FY2022 (-0.53 pp) and 78.57% in FY2021 (+6.26 pp).
  • Quarterly Gross Margin has run from a low of 61.01% in Q4 2024 to a high of 80.34% in Q4 2021 over five years.
  • On a year-over-year basis, Gross Margin increased in 1 of the last eight quarters, with an average year-over-year change of -2.64 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2021, with a gain of 6.63 percentage points; the weakest was Q4 2024, with a drop of 15.07 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 70.22% (Q1 2026), 67.23% (Q4 2025) and 71.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 68.19%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 74.74%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 73.54%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 78.02%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 83.60%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 72.04%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 79.76%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 72.78%
10 Bristol Myers Squibb 126.07 Bn 77.35 Bn 9.25 Bn 71.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.28%
Mar 31, 2026 70.22%
Dec 31, 2025 67.23%
Sep 30, 2025 71.89%
Jun 30, 2025 72.52%
Mar 31, 2025 72.92%
Dec 31, 2024 61.01%
Sep 30, 2024 75.13%
Jun 30, 2024 73.22%
Mar 31, 2024 75.29%
Dec 31, 2023 76.08%
Sep 30, 2023 77.15%
Jun 30, 2023 74.38%
Mar 31, 2023 77.37%
Dec 31, 2022 77.27%
Sep 30, 2022 79.02%
Jun 30, 2022 77.12%
Mar 31, 2022 78.79%
Dec 31, 2021 80.34%
Sep 30, 2021 80.29%
API Access

Bristol Myers Squibb Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY